Supply of nirmatrelvir/ritonavir and molnupiravir for patients with COVID-19 in the first eight months since listing on the Australian Pharmaceutical Benefits Scheme: A retrospective observational study

Autor: Lopez, Derrick, Pritchard, Douglas, Sanfilippo, Frank M., Kelty, Erin, Page, Amy, Etherton-Beer, Christopher, Almeida, Osvaldo P., Preen, David B.
Zdroj: In Infectious Diseases Now September 2024 54(6)
Databáze: ScienceDirect
Externí odkaz: